Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
Hims & Hers May Face FTC Lawsuit for Allegedly Sharing Sensitive User Data With Advertisers: Report
03:06pm, Wednesday, 29'th Jul 2026
The U.S. Federal Trade Commission (FTC) is reportedly launching a major lawsuit against Hims & Hers Health Inc. (NYSE:HIMS) , claiming the telehealth company unlawfully shared sensitive customer healt
Hims and Hers shares fall 10% as FTC sues company over data, billing practices
02:24pm, Wednesday, 29'th Jul 2026
The FTC alleged Hims & Hers shared sensitive user health information with advertisers including Meta and Snap through tracking technologies without proper consent. Regulators also accuse the telehealt
FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech
02:05pm, Wednesday, 29'th Jul 2026
2.6 million. That's how many people subscribe to Him & Hers for personal health, skin care, hair loss treatments and weight-loss management, according to the company's first quarter results, up 9% yea
Hims & Hers Responds to FTC Lawsuit
02:00pm, Wednesday, 29'th Jul 2026
Hims and Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC):This lawsuit disregards substantial evidence we
Hims & Hers Responds to FTC Lawsuit
01:51pm, Wednesday, 29'th Jul 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provid
US FTC suing Hims & Hers for sending user health info to Meta, Snap
12:34pm, Wednesday, 29'th Jul 2026
The U.S. Federal Trade Commission is suing Hims & Hers alleging the telehealth platform shared users' health data with online advertisers despite promising privacy and engaged in deceptive billi
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
06:45pm, Tuesday, 28'th Jul 2026
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.32, indicating a -3.04% shift from the previous trading day.
Understanding The AI Flywheel At Hims And Hers
06:13am, Tuesday, 28'th Jul 2026
Hims & Hers is a subscriber-based online healthcare provider that operates outside of the traditional paradigm. Its AI-native processes and visibility to each patient's full medical journey create a f
Hims & Hers: Peptide Ruling A Positive, Operational Good Sense Makes 'Buy' Case (Upgrade)
12:12pm, Friday, 24'th Jul 2026
Hims & Hers Health is upgraded from "Hold" to "Buy," driven by operational discipline and strategic opportunism despite sector volatility. HIMS leverages FDA panel momentum on peptides, expanding into
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?
10:00am, Friday, 24'th Jul 2026
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight
08:15am, Friday, 24'th Jul 2026
Hims & Hers Health Inc. (NYSE:HIMS) is in the spotlight Friday after an FDA advisory panel voted Thursday to recommend four key peptides be added to a federal list that would allow compounding pharmac
QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'
03:15pm, Thursday, 23'rd Jul 2026
Martin Shkreli is taking aim at Hims & Hers Health (NYSE:HIMS), saying he is short the stock and blasting the company's peptide products as illegitimate medicine
Hims & Hers stands to gain if the FDA loosens restrictions on peptides
06:03am, Thursday, 23'rd Jul 2026
Hims & Hers Health is set to tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions.
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
06:46pm, Wednesday, 22'nd Jul 2026
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.68, moving 3.21% from the previous trading session.
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
04:17pm, Friday, 17'th Jul 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company af
